10x Genomics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
605.23 |
587.01 |
620.75 |
676.82 |
716.18 |
747.47 |
| Przychód Δ r/r |
0.00% |
-3.01% |
5.75% |
9.03% |
5.82% |
4.37% |
| Przychód (min) |
599.12 |
566.54 |
580.28 |
676.48 |
684.48 |
714.38 |
| Przychód (max) |
612.11 |
613.99 |
688.97 |
677.15 |
769.81 |
803.44 |
| EBITDA (średnia) |
-223.91 |
-217.18 |
-229.66 |
-250.40 |
-264.96 |
-276.54 |
| EBIT (średnia) |
-255.82 |
-248.12 |
-262.38 |
-286.08 |
-302.72 |
-315.94 |
| EBIT % |
-42.27% |
-42.27% |
-42.27% |
-42.27% |
-42.27% |
-42.27% |
| Zysk netto (średni) |
-168.97 |
-146.96 |
-111.26 |
-93.09 |
-79.50 |
-114.83 |
| Zysk netto % |
-27.92% |
-25.03% |
-17.92% |
-13.75% |
-11.10% |
-15.36% |
| EPS (średnia) |
-1.41 |
-1.22 |
-0.94 |
-0.62 |
-0.66 |
-0.95 |
| Liczba analityków (Przychody) |
7 |
11 |
15 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
9 |
5 |
8 |
8 |
7 |
6 |
| symbol |
TXG |
TXG |
TXG |
TXG |
TXG |
TXG |